[{"edinetCode":"E04950","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":788.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2348000.0,"sharesOwendPercent":0.557,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2007.21,"equityRatio":0.718,"cashAndCashEquivalents":3083629000.0,"assets":9727775000.0,"currentAssets":6611308000.0,"fixedAsset":3116467000.0,"tangibleFixedAssets":2343780000.0,"intangibleFixedAssets":97746000.0,"investmentAndOtherAssets":674940000.0,"liabilities":2743853000.0,"currentLiabilities":2488453000.0,"shorTermDept":13316000.0,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":255400000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":6983921000.0,"capitalStock":6953377000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":5459411000.0,"treasuryStock":-504653000.0,"valuationAndConversionAdjustments":30543000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17055196000.0,"costOfSales":11965909000.0,"grossProfit":5089286000.0,"sgaExpenses":4317574000.0,"salaryAndBenefit":null,"depreciationAndSGA":131546000.0,"RDExpenses":12081000.0,"operatingIncome":771711000.0,"nonOperatingIncome":90440000.0,"nonOperatingExpenses":58162000.0,"interestExpense":1607000.0,"ordinaryProfit":803990000.0,"extraordinaryGain":507000.0,"extraordinaryLoss":58402000.0,"incomeBeforeTax":746095000.0,"incomeTaxes":232220000.0,"netIncome":513874000.0,"netIncomeAttributableToOwnersOfTheParentCompany":513874000.0,"comprehensiveIncome":538409000.0,"eps":147.69,"dilutedEps":null,"dividendPerShare":null,"per":8.42,"roe":0.076,"cashFlowFromOperatingActivities":669545000.0,"depreciationAndCashflowFromOperatingActivities":333697000.0,"cashFlowFromInvestingActivities":-529616000.0,"cashFlowFromFinancialActivities":-73528000.0,"changesInCashAndCashEquivalents":66400000.0,"列1":"asr","submitDate":"2017\/6\/27","stockCode":9776,"accountingYear":"第53期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":781.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2486000.0,"sharesOwendPercent":0.718,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2194.08,"equityRatio":0.717,"cashAndCashEquivalents":4005761000.0,"assets":10591147000.0,"currentAssets":7488850000.0,"fixedAsset":3102297000.0,"tangibleFixedAssets":2379421000.0,"intangibleFixedAssets":83894000.0,"investmentAndOtherAssets":638981000.0,"liabilities":2994012000.0,"currentLiabilities":2729142000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":264869000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7597135000.0,"capitalStock":7571518000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":6109905000.0,"treasuryStock":-537007000.0,"valuationAndConversionAdjustments":25617000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17459961000.0,"costOfSales":12085593000.0,"grossProfit":5374368000.0,"sgaExpenses":4357384000.0,"salaryAndBenefit":null,"depreciationAndSGA":128188000.0,"RDExpenses":11203000.0,"operatingIncome":1016984000.0,"nonOperatingIncome":83197000.0,"nonOperatingExpenses":46782000.0,"interestExpense":1582000.0,"ordinaryProfit":1053398000.0,"extraordinaryGain":1233000.0,"extraordinaryLoss":2346000.0,"incomeBeforeTax":1052286000.0,"incomeTaxes":366997000.0,"netIncome":685288000.0,"netIncomeAttributableToOwnersOfTheParentCompany":685288000.0,"comprehensiveIncome":680362000.0,"eps":197.03,"dilutedEps":null,"dividendPerShare":null,"per":11.42,"roe":0.094,"cashFlowFromOperatingActivities":1310188000.0,"depreciationAndCashflowFromOperatingActivities":342058000.0,"cashFlowFromInvestingActivities":-293066000.0,"cashFlowFromFinancialActivities":-94989000.0,"changesInCashAndCashEquivalents":922131000.0,"列1":"asr","submitDate":"2018\/6\/26","stockCode":9776,"accountingYear":"第54期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":810.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2547000.0,"sharesOwendPercent":0.744,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2331.49,"equityRatio":0.747,"cashAndCashEquivalents":4426980000.0,"assets":10677540000.0,"currentAssets":7762145000.0,"fixedAsset":2915394000.0,"tangibleFixedAssets":2108906000.0,"intangibleFixedAssets":53566000.0,"investmentAndOtherAssets":752921000.0,"liabilities":2696162000.0,"currentLiabilities":2430963000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":265199000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":7981377000.0,"capitalStock":7960574000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":6595116000.0,"treasuryStock":-633162000.0,"valuationAndConversionAdjustments":20802000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17065603000.0,"costOfSales":11866989000.0,"grossProfit":5198613000.0,"sgaExpenses":4383198000.0,"salaryAndBenefit":null,"depreciationAndSGA":127151000.0,"RDExpenses":9681000.0,"operatingIncome":815415000.0,"nonOperatingIncome":73085000.0,"nonOperatingExpenses":75334000.0,"interestExpense":1604000.0,"ordinaryProfit":813167000.0,"extraordinaryGain":76562000.0,"extraordinaryLoss":71567000.0,"incomeBeforeTax":818162000.0,"incomeTaxes":294863000.0,"netIncome":523299000.0,"netIncomeAttributableToOwnersOfTheParentCompany":523299000.0,"comprehensiveIncome":518485000.0,"eps":152.42,"dilutedEps":null,"dividendPerShare":null,"per":12.92,"roe":0.067,"cashFlowFromOperatingActivities":646657000.0,"depreciationAndCashflowFromOperatingActivities":308629000.0,"cashFlowFromInvestingActivities":-79841000.0,"cashFlowFromFinancialActivities":-145597000.0,"changesInCashAndCashEquivalents":421218000.0,"列1":"asr","submitDate":"2019\/6\/25","stockCode":9776,"accountingYear":"第55期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.721,"cashAndCashEquivalents":null,"assets":11266553000.0,"currentAssets":5767665000.0,"fixedAsset":5498888000.0,"tangibleFixedAssets":4704304000.0,"intangibleFixedAssets":48145000.0,"investmentAndOtherAssets":746438000.0,"liabilities":3146263000.0,"currentLiabilities":2867696000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":278567000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8120290000.0,"capitalStock":8106262000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":6740805000.0,"treasuryStock":-633162000.0,"valuationAndConversionAdjustments":14027000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":4426700000.0,"costOfSales":3037279000.0,"grossProfit":1389420000.0,"sgaExpenses":1122224000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":267196000.0,"nonOperatingIncome":18202000.0,"nonOperatingExpenses":13771000.0,"interestExpense":356000.0,"ordinaryProfit":271627000.0,"extraordinaryGain":null,"extraordinaryLoss":27000.0,"incomeBeforeTax":271600000.0,"incomeTaxes":91678000.0,"netIncome":179921000.0,"netIncomeAttributableToOwnersOfTheParentCompany":179921000.0,"comprehensiveIncome":173145000.0,"eps":52.56,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":9776,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2548000.0,"sharesOwendPercent":0.7446,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.734,"cashAndCashEquivalents":2403947000.0,"assets":11262835000.0,"currentAssets":5735361000.0,"fixedAsset":5527474000.0,"tangibleFixedAssets":4744103000.0,"intangibleFixedAssets":46801000.0,"investmentAndOtherAssets":736569000.0,"liabilities":2991179000.0,"currentLiabilities":2706358000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":284821000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8271656000.0,"capitalStock":8252412000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":6886954000.0,"treasuryStock":-633162000.0,"valuationAndConversionAdjustments":19243000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":8838310000.0,"costOfSales":6075581000.0,"grossProfit":2762729000.0,"sgaExpenses":2270005000.0,"salaryAndBenefit":983061000.0,"depreciationAndSGA":54989000.0,"RDExpenses":null,"operatingIncome":492723000.0,"nonOperatingIncome":41894000.0,"nonOperatingExpenses":26550000.0,"interestExpense":904000.0,"ordinaryProfit":508066000.0,"extraordinaryGain":null,"extraordinaryLoss":17561000.0,"incomeBeforeTax":490505000.0,"incomeTaxes":164434000.0,"netIncome":326070000.0,"netIncomeAttributableToOwnersOfTheParentCompany":326070000.0,"comprehensiveIncome":324511000.0,"eps":95.25,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":710742000.0,"depreciationAndCashflowFromOperatingActivities":113127000.0,"cashFlowFromInvestingActivities":-2691484000.0,"cashFlowFromFinancialActivities":-42290000.0,"changesInCashAndCashEquivalents":-2023032000.0,"列1":"q2r","submitDate":"2019\/11\/13","stockCode":9776,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.72,"cashAndCashEquivalents":null,"assets":11741253000.0,"currentAssets":6193259000.0,"fixedAsset":5547993000.0,"tangibleFixedAssets":4787985000.0,"intangibleFixedAssets":43702000.0,"investmentAndOtherAssets":716305000.0,"liabilities":3293396000.0,"currentLiabilities":2990476000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":302919000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8447857000.0,"capitalStock":8421958000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7056500000.0,"treasuryStock":-633162000.0,"valuationAndConversionAdjustments":25898000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":13345267000.0,"costOfSales":9152842000.0,"grossProfit":4192425000.0,"sgaExpenses":3462481000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":729943000.0,"nonOperatingIncome":73773000.0,"nonOperatingExpenses":40921000.0,"interestExpense":1526000.0,"ordinaryProfit":762796000.0,"extraordinaryGain":90000.0,"extraordinaryLoss":17574000.0,"incomeBeforeTax":745313000.0,"incomeTaxes":249696000.0,"netIncome":495616000.0,"netIncomeAttributableToOwnersOfTheParentCompany":495616000.0,"comprehensiveIncome":500712000.0,"eps":144.78,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/13","stockCode":9776,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":820.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2561000.0,"sharesOwendPercent":0.7481,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2472.23,"equityRatio":0.733,"cashAndCashEquivalents":2717730000.0,"assets":11553144000.0,"currentAssets":5931708000.0,"fixedAsset":5621436000.0,"tangibleFixedAssets":4864900000.0,"intangibleFixedAssets":45789000.0,"investmentAndOtherAssets":710745000.0,"liabilities":3089998000.0,"currentLiabilities":2795724000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":294274000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8463145000.0,"capitalStock":8454500000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7089087000.0,"treasuryStock":-633207000.0,"valuationAndConversionAdjustments":8645000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17659084000.0,"costOfSales":12139165000.0,"grossProfit":5519918000.0,"sgaExpenses":4574976000.0,"salaryAndBenefit":null,"depreciationAndSGA":116301000.0,"RDExpenses":9306000.0,"operatingIncome":944942000.0,"nonOperatingIncome":93762000.0,"nonOperatingExpenses":55721000.0,"interestExpense":2175000.0,"ordinaryProfit":982982000.0,"extraordinaryGain":90000.0,"extraordinaryLoss":137814000.0,"incomeBeforeTax":845259000.0,"incomeTaxes":317054000.0,"netIncome":528204000.0,"netIncomeAttributableToOwnersOfTheParentCompany":528204000.0,"comprehensiveIncome":516047000.0,"eps":154.3,"dilutedEps":null,"dividendPerShare":null,"per":10.36,"roe":0.064,"cashFlowFromOperatingActivities":1255547000.0,"depreciationAndCashflowFromOperatingActivities":244731000.0,"cashFlowFromInvestingActivities":-2913165000.0,"cashFlowFromFinancialActivities":-51630000.0,"changesInCashAndCashEquivalents":-1709249000.0,"列1":"asr","submitDate":"2020\/6\/25","stockCode":9776,"accountingYear":"第56期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.734,"cashAndCashEquivalents":null,"assets":11496763000.0,"currentAssets":5578334000.0,"fixedAsset":5918428000.0,"tangibleFixedAssets":5164384000.0,"intangibleFixedAssets":43253000.0,"investmentAndOtherAssets":710791000.0,"liabilities":3057623000.0,"currentLiabilities":2786853000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":270769000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8439140000.0,"capitalStock":8418943000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7053531000.0,"treasuryStock":-633207000.0,"valuationAndConversionAdjustments":20196000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":4074046000.0,"costOfSales":2882055000.0,"grossProfit":1191990000.0,"sgaExpenses":1158091000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":33898000.0,"nonOperatingIncome":18027000.0,"nonOperatingExpenses":12146000.0,"interestExpense":534000.0,"ordinaryProfit":39779000.0,"extraordinaryGain":null,"extraordinaryLoss":11735000.0,"incomeBeforeTax":28043000.0,"incomeTaxes":29367000.0,"netIncome":-1323000.0,"netIncomeAttributableToOwnersOfTheParentCompany":-1323000.0,"comprehensiveIncome":10226000.0,"eps":-0.39,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/11","stockCode":9776,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2560000.0,"sharesOwendPercent":0.748,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.759,"cashAndCashEquivalents":2364617000.0,"assets":11433231000.0,"currentAssets":5526473000.0,"fixedAsset":5906757000.0,"tangibleFixedAssets":5159245000.0,"intangibleFixedAssets":40378000.0,"investmentAndOtherAssets":707134000.0,"liabilities":2757389000.0,"currentLiabilities":2492892000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":264497000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8675842000.0,"capitalStock":8645786000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7280374000.0,"treasuryStock":-633207000.0,"valuationAndConversionAdjustments":30055000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":8364332000.0,"costOfSales":5714150000.0,"grossProfit":2650182000.0,"sgaExpenses":2281616000.0,"salaryAndBenefit":1003229000.0,"depreciationAndSGA":46261000.0,"RDExpenses":null,"operatingIncome":368566000.0,"nonOperatingIncome":35912000.0,"nonOperatingExpenses":28135000.0,"interestExpense":1214000.0,"ordinaryProfit":376343000.0,"extraordinaryGain":400000.0,"extraordinaryLoss":11735000.0,"incomeBeforeTax":365008000.0,"incomeTaxes":139488000.0,"netIncome":225519000.0,"netIncomeAttributableToOwnersOfTheParentCompany":225519000.0,"comprehensiveIncome":246928000.0,"eps":65.88,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":146128000.0,"depreciationAndCashflowFromOperatingActivities":119592000.0,"cashFlowFromInvestingActivities":-454469000.0,"cashFlowFromFinancialActivities":-44772000.0,"changesInCashAndCashEquivalents":-353113000.0,"列1":"q2r","submitDate":"2020\/11\/11","stockCode":9776,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.737,"cashAndCashEquivalents":null,"assets":12114923000.0,"currentAssets":5570412000.0,"fixedAsset":6544510000.0,"tangibleFixedAssets":5801531000.0,"intangibleFixedAssets":38740000.0,"investmentAndOtherAssets":704239000.0,"liabilities":3186271000.0,"currentLiabilities":2918163000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":268107000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":8928652000.0,"capitalStock":8903520000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7538108000.0,"treasuryStock":-633207000.0,"valuationAndConversionAdjustments":25131000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":12985355000.0,"costOfSales":8784286000.0,"grossProfit":4201068000.0,"sgaExpenses":3453059000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":748009000.0,"nonOperatingIncome":52508000.0,"nonOperatingExpenses":41356000.0,"interestExpense":1869000.0,"ordinaryProfit":759160000.0,"extraordinaryGain":413000.0,"extraordinaryLoss":12024000.0,"incomeBeforeTax":747549000.0,"incomeTaxes":264296000.0,"netIncome":483253000.0,"netIncomeAttributableToOwnersOfTheParentCompany":483253000.0,"comprehensiveIncome":499739000.0,"eps":141.17,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":9776,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":819.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2556000.0,"sharesOwendPercent":0.7469,"outstandingShares":null,"numberOfSubsidiary":2.0,"bps":2708.63,"equityRatio":0.639,"cashAndCashEquivalents":2350691000.0,"assets":14511471000.0,"currentAssets":5912539000.0,"fixedAsset":8598931000.0,"tangibleFixedAssets":7757671000.0,"intangibleFixedAssets":42154000.0,"investmentAndOtherAssets":799106000.0,"liabilities":5239086000.0,"currentLiabilities":3105932000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":133987000.0,"fixedLiabilities":2133154000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1866013000.0,"netAsset":9272384000.0,"capitalStock":9213955000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7848543000.0,"treasuryStock":-633207000.0,"valuationAndConversionAdjustments":58429000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":17502544000.0,"costOfSales":11767659000.0,"grossProfit":5734884000.0,"sgaExpenses":4592539000.0,"salaryAndBenefit":null,"depreciationAndSGA":111043000.0,"RDExpenses":8242000.0,"operatingIncome":1142345000.0,"nonOperatingIncome":102198000.0,"nonOperatingExpenses":56398000.0,"interestExpense":2575000.0,"ordinaryProfit":1188144000.0,"extraordinaryGain":413000.0,"extraordinaryLoss":12630000.0,"incomeBeforeTax":1175928000.0,"incomeTaxes":382239000.0,"netIncome":793688000.0,"netIncomeAttributableToOwnersOfTheParentCompany":793688000.0,"comprehensiveIncome":843471000.0,"eps":231.85,"dilutedEps":null,"dividendPerShare":null,"per":6.61,"roe":0.09,"cashFlowFromOperatingActivities":837590000.0,"depreciationAndCashflowFromOperatingActivities":271274000.0,"cashFlowFromInvestingActivities":-3148264000.0,"cashFlowFromFinancialActivities":1943634000.0,"changesInCashAndCashEquivalents":-367039000.0,"列1":"asr","submitDate":"2021\/6\/25","stockCode":9776,"accountingYear":"第57期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.63,"cashAndCashEquivalents":null,"assets":14668443000.0,"currentAssets":5752149000.0,"fixedAsset":8916293000.0,"tangibleFixedAssets":8105306000.0,"intangibleFixedAssets":40068000.0,"investmentAndOtherAssets":770918000.0,"liabilities":5204715000.0,"currentLiabilities":3109227000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":133692000.0,"fixedLiabilities":2095488000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1832590000.0,"netAsset":9463728000.0,"capitalStock":9216462000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":7876967000.0,"treasuryStock":-659124000.0,"valuationAndConversionAdjustments":28320000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":4638812000.0,"costOfSales":3103187000.0,"grossProfit":1535625000.0,"sgaExpenses":1243239000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":292385000.0,"nonOperatingIncome":17948000.0,"nonOperatingExpenses":16753000.0,"interestExpense":2233000.0,"ordinaryProfit":293581000.0,"extraordinaryGain":42000.0,"extraordinaryLoss":102376000.0,"incomeBeforeTax":191247000.0,"incomeTaxes":85143000.0,"netIncome":106104000.0,"netIncomeAttributableToOwnersOfTheParentCompany":107158000.0,"comprehensiveIncome":75995000.0,"eps":31.31,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/10","stockCode":9776,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":2549000.0,"sharesOwendPercent":0.7482,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.628,"cashAndCashEquivalents":2970223000.0,"assets":15279579000.0,"currentAssets":6493342000.0,"fixedAsset":8786236000.0,"tangibleFixedAssets":7944568000.0,"intangibleFixedAssets":122938000.0,"investmentAndOtherAssets":718729000.0,"liabilities":5457758000.0,"currentLiabilities":3389585000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":133692000.0,"fixedLiabilities":2068172000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1799167000.0,"netAsset":9821821000.0,"capitalStock":9567278000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":8227783000.0,"treasuryStock":-659124000.0,"valuationAndConversionAdjustments":35841000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":9566372000.0,"costOfSales":6356915000.0,"grossProfit":3209457000.0,"sgaExpenses":2432273000.0,"salaryAndBenefit":1048730000.0,"depreciationAndSGA":70516000.0,"RDExpenses":null,"operatingIncome":777183000.0,"nonOperatingIncome":75630000.0,"nonOperatingExpenses":31953000.0,"interestExpense":4595000.0,"ordinaryProfit":820861000.0,"extraordinaryGain":133000.0,"extraordinaryLoss":103825000.0,"incomeBeforeTax":717169000.0,"incomeTaxes":260492000.0,"netIncome":456676000.0,"netIncomeAttributableToOwnersOfTheParentCompany":457975000.0,"comprehensiveIncome":434088000.0,"eps":134.13,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":1013103000.0,"depreciationAndCashflowFromOperatingActivities":248426000.0,"cashFlowFromInvestingActivities":-429785000.0,"cashFlowFromFinancialActivities":36212000.0,"changesInCashAndCashEquivalents":619531000.0,"列1":"q2r","submitDate":"2021\/11\/10","stockCode":9776,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0},{"edinetCode":"E04950","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.632,"cashAndCashEquivalents":null,"assets":15510626000.0,"currentAssets":6695036000.0,"fixedAsset":8815589000.0,"tangibleFixedAssets":7952606000.0,"intangibleFixedAssets":128646000.0,"investmentAndOtherAssets":734335000.0,"liabilities":5487016000.0,"currentLiabilities":3458827000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":135367000.0,"fixedLiabilities":2028189000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":1765744000.0,"netAsset":10023609000.0,"capitalStock":9771101000.0,"capital":983350000.0,"capitalSurplus":1015270000.0,"accumulatedEarnings":8431606000.0,"treasuryStock":-659124000.0,"valuationAndConversionAdjustments":34155000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":14285788000.0,"costOfSales":9558379000.0,"grossProfit":4727408000.0,"sgaExpenses":3641047000.0,"salaryAndBenefit":null,"depreciationAndSGA":null,"RDExpenses":null,"operatingIncome":1086360000.0,"nonOperatingIncome":101393000.0,"nonOperatingExpenses":48277000.0,"interestExpense":6869000.0,"ordinaryProfit":1139476000.0,"extraordinaryGain":133000.0,"extraordinaryLoss":114753000.0,"incomeBeforeTax":1024857000.0,"incomeTaxes":364707000.0,"netIncome":660150000.0,"netIncomeAttributableToOwnersOfTheParentCompany":661798000.0,"comprehensiveIncome":635876000.0,"eps":193.96,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":9776,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E04950","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":983,"settlementDate":"2022\/3\/31","submitterName":"札幌臨床検査センター株式会社","submitterNameEnglish":"SAPPORO CLINICAL LABORATORY INC.","submitterNameKana":"サッポロリンショウケンサセンターカブシキガイシャ","location":"札幌市中央区北５条西１８丁目９番地１","industory":"サービス業","corporateNumber":7430000000000.0}]